Clinical Trials Browser

Has announcements × Lymphoma, B-Cell, Marginal Zone × tafasitamab × Clear all

NCT04680052 2025-12-22

InMIND

Phase 3 Active not recruiting

654 enrolled 40 charts 1 FDA

Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone